In addition to this, cancer cells presenting KRAS mutations also depend on cCAT to sustain their proliferation and survival by reprogramming glutamine metabolism, as described in pancreas cancer [76,77]. This evidence concerns the gene GOT1 and pancreatic neoplasm.